Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1016-2022Class II

Empower Introducer Sheath with Hydrophilic Coating 21F x 56cm Model: 668782-100 (US)

Freudenberg Medical, LLC / initiated 2022-02-21 / Terminated / root cause: manufacturing process

Freudenberg Medical, Llc began a recall of Empower Introducer Sheath with Hydrophilic Coating 21F x 56cm Model: 668782-100 (US) on . FDA classified it as Class II and gives the reason as "Non-intended glue from the hub/shaft bond on the inside ID of the catheter shaft may cause Embolism leading to peripheral ischemia". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1016-2022
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Freudenberg Medical, LLC
Product
Empower Introducer Sheath with Hydrophilic Coating 21F x 56cm Model: 668782-100 (US)
Product code
DYB Introducer, Catheter
Reason for recall
Non-intended glue from the hub/shaft bond on the inside ID of the catheter shaft may cause Embolism leading to peripheral ischemia
Root cause tag
manufacturing process
FDA root cause
Process control
Action
Boston Scientific issued letter dated Feb 2022 -Model 8782 EMPOWER" Introducer Sheath Product Retrieval and MODULAR ATP Clinical Study Temporary Enrollment Suspension. Letter states reason, health risk and action to take: 1. Immediately segregate all affected product to ensure that it will not be used. 2. Your local Field Clinical Engineer will retrieve and return affected product and assist you in completing the enclosed Reply Verification Tracking Form. 3. Do not enroll new patients into the MODULAR ATP Clinical Study until further communication from Boston Scientific is received. 4. Continue following enrolled patients per protocol. 5. Communicate with your IRB/ EC as required by your site. BSC recognizes the impact of communications on both you and your patients. We are committed to transparent communication with healthcare professionals to ensure you have timely, relevant information for managing your patients and conduct this clinical study with the highest quality and ethical standards. If you have further questions, please contact Ken Stein, MD, Sr. Vice President and Chief Medical Officer, Boston Scientific Rhythm Management
Quantity in commerce
13 units (US)
Distribution
US distribution: GA, OH Foreign distribution: Netherlands
Product codes and lots
Lot Numbers: PD01, PD00013140  UDI: 00850004312001

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1016-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1016-2022Class IITerminatedVoluntary: Firm initiated
Z-1017-2022Class IITerminatedVoluntary: Firm initiated